These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33363494)

  • 1. Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?
    Alvisi MF; Dordoni P; Rancati T; Avuzzi B; Nicolai N; Badenchini F; De Luca L; Magnani T; Marenghi C; Menichetti J; Silvia V; Fabiana Z; Roberto S; Riccardo V; Lara B;
    Front Psychol; 2020; 11():576459. PubMed ID: 33363494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.
    Dordoni P; Remmers S; Valdagni R; Bellardita L; De Luca L; Badenchini F; Marenghi C; Roobol MJ; Venderbos LDF
    BMC Urol; 2022 Jul; 22(1):110. PubMed ID: 35850672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.
    Alvisi MF; Repetto C; Rancati T; Badenchini F; Magnani T; Marenghi C; Villa S; Nicolai N; Salvioni R; Avuzzi B; Valdagni R; Bellardita L;
    Tumori; 2018 Jun; 104(3):172-178. PubMed ID: 28623635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
    Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
    Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy].
    de la Taille A; Mardoyan S; Lafaye A
    Prog Urol; 2018 Jan; 28(1):32-38. PubMed ID: 29223415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
    Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
    J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.
    Tavlarides AM; Ames SC; Thiel DD; Diehl NN; Parker AS
    Psychooncology; 2015 Apr; 24(4):451-7. PubMed ID: 24953309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
    Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
    BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: A 9-month longitudinal study.
    Ruane-McAteer E; Porter S; O'Sullivan J; Dempster M; Prue G
    Psychooncology; 2019 Aug; 28(8):1743-1752. PubMed ID: 31243872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do prostate cancer patients navigate the active surveillance journey? A 3-year longitudinal study.
    Dordoni P; Badenchini F; Alvisi MF; Menichetti J; De Luca L; Di Florio T; Magnani T; Marenghi C; Rancati T; Valdagni R; Bellardita L
    Support Care Cancer; 2021 Feb; 29(2):645-651. PubMed ID: 32424643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and distress during active surveillance for early prostate cancer.
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
    Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
    Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
    Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer.
    Naha U; Freedland SJ; Abern MR; Moreira DM
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):335-340. PubMed ID: 32901094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men.
    Touzani R; Mancini J; Troïan J; Bouhnik AD; Cussenot O; Gravis G; Marino P
    J Patient Rep Outcomes; 2019 Sep; 3(1):60. PubMed ID: 31493106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.
    Venderbos LDF; Aluwini S; Roobol MJ; Bokhorst LP; Oomens EHGM; Bangma CH; Korfage IJ
    Qual Life Res; 2017 Jun; 26(6):1635-1645. PubMed ID: 28168601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up in Active Surveillance for Prostate Cancer: Strict Protocol Adherence Remains Important for PRIAS-ineligible Patients.
    Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2019 Sep; 2(5):483-489. PubMed ID: 31411970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.